EichorEICHOR
Location: Ede Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Ede

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Rehabilitation After a Hip Fracture: the Effects of Dietary Protein and Exercise on Bone and Muscle Health and Quality o
NA · Gelderse Vallei Hospital · Wageningen University · NCT07036341
Screening for Malnutrition in Obese Patients
Phase N/A · Ziekenhuis Gelderse Vallei · HAN University of Applied Sciences · NCT06626360
Dietary Fiber Before Colorectal Cancer Surgery
NA · Ziekenhuis Gelderse Vallei · Wageningen University · NCT06212817
Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Gelderse Vallei Hospital · Maastricht University Medical Center · NCT04486495
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738
The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients
NA · Gelderse Vallei Hospital · Gelderse Vallei Hospital · NCT07173504
Effect of Collagen/Vitamin C in Jumper's Knee; a RCT
NA · Gelderse Vallei Hospital · Gelderse Vallei Hospital · NCT05407194
Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA
Phase N/A · Ziekenhuis Gelderse Vallei · Rijnstate Hospital · NCT04183426
Prospective Data Collection Initiative on Thoracic Malignancies
Phase N/A · Ziekenhuis Gelderse Vallei · Dutch Society of Physicians for Pulmonology and Tuberculosis · NCT06996249
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109
Long-Term Outcomes and Post-Intensive Care Syndrome: Investigating the Associations Between Metabolic Signatures and Phy
Phase N/A · Gelderse Vallei Hospital · ARH van Zanten, MD PhD · NCT07170527
Protein Dosing Strategies in Critically Ill Patients: Comparing Actual Body Weight and Fat-Free Mass Approaches in an Ob
Phase N/A · Gelderse Vallei Hospital · Gelderse Vallei Hospital · NCT07312708
The Effect of Muscle Stimulation and Amino Acid Intake on Protein Metabolism During Critical Illness
NA · Hospital Gelderse Vallei · Wageningen University · NCT07430969
Prospective Bladder Cancer Infrastructure (ProBCI)
Phase N/A · Ziekenhuis Gelderse Vallei · Prospective Bladder Cancer Infrastructure Foundation · NCT04503577
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Phase 2 · NL-Ede-ZGV · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT04523428
Prospective Data Collection Initiative on Colorectal Cancer
Phase N/A · Ziekenhuis Gelderse Vallei · Dutch Colorectal Cancer Group · NCT02070146
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
NA · Ziekenhuis Gelderse Vallei · Radboud University Medical Center · NCT05779631
The TASTY-steering Study
NA · Ziekenhuisvoorzieningen Gelderse Vallei · University Medical Center Groningen · NCT07258563
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NA · Ziekenhuis Gelderse Vallei · Radboud University Medical Center · NCT06082492
FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethas
Phase 3 · NL-Ede-ZGV · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT06187441
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infi
Phase N/A · Medical spectrum Twente · The Netherlands Cancer Institute · NCT06476119
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Monocacy Surgery Center, LLC · Stryker Instruments · NCT03072927
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Phase 2 · Gelderse Vallei Hospital · BioAegis Therapeutics Inc. · NCT05947955
MAD Trial: Myopia Atropine Dose
Phase 3 · Bergman Clinics - Ede · Erasmus Medical Center · NCT05667454
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · Dr. Everett Chalmers Regional Hospital · UMC Utrecht · NCT02735707
Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276
The Drug Rediscovery Protocol (DRUP Trial)
Phase 2 · Ziekenhuis Gelderse Vallei · The Netherlands Cancer Institute · NCT02925234
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL o
Phase 1/Phase 2 · NL-Ede-ZGV · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT05791409
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Centro de Investigaciones Metabólicas · Novo Nordisk A/S · NCT07567001
Look up another city
Look up another condition